Ocular-brain co-immunotherapy targeting amyloid-beta in Alzheimer's disease:Challenges and promising therapeutic avenues
摘要 Alzheimer's disease is an ocular-brain comorbidity:Alzheimer's disease(AD)is a leading neurodegenerative disorder affecting the central nervous system(CNS),clinically characterized by progressive cognitive decline,neuropsychiatric disturbances,and memory deficits.
更多
作者单位
Dr.Neher's Biophysics Laboratory for Innovative Drug Discovery,State Key Laboratory of Quality Research in Chinese Medicine,Faculty of Chinese Medicine,Macau University of Science and Technology,Macao Special Administrative Region,China;Department of Ophthalmology,Affiliated Hospital of Southwest Medical University,Luzhou,Sichuan Province,China
[1]
College of Integration of Traditional Chinese and Western Medicine & The Affiliated Traditional Chinese Medicine Hospital,Southwest Medical University,Luzhou,Sichuan Province,China
[2]
Dr.Neher's Biophysics Laboratory for Innovative Drug Discovery,State Key Laboratory of Quality Research in Chinese Medicine,Faculty of Chinese Medicine,Macau University of Science and Technology,Macao Special Administrative Region,China
[3]
Department of Ophthalmology,Affiliated Hospital of Southwest Medical University,Luzhou,Sichuan Province,China
[4]
DOI
10.4103/NRR.NRR-D-25-01399
发布时间
2026-06-25（万方平台首次上网日期，不代表论文的发表时间）
中国神经再生研究（英文版）
换一批
